Search in:

Journal of Multidisciplinary Healthcare Volume 8, 2015 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Perspectives

Radium-223 dichloride: illustrating the benefits of a multidisciplinary approach for patients with metastatic castration-resistant prostate cancer

Joseph F Renzulli IIGenitourinary Multidisciplinary Clinic, The Miriam Hospital, Providence, RI, USACorrespondence[email protected]

Jennifer CollinsGenitourinary Multidisciplinary Clinic, The Miriam Hospital, Providence, RI, USA

Anthony MegaGenitourinary Multidisciplinary Clinic, The Miriam Hospital, Providence, RI, USA

Pages 279-286 | Published online: 05 Jun 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (12)

Amit Bhoil, Phei Shan Chuah, Nagabhushan Seshadri & Sobhan Vinjamuri. (2022) Factors Influencing Outcome Post–Radium-223 Dichloride in Castrate Resistant Prostate Cancer: A Review of Some Real-World Challenges. World Journal of Nuclear Medicine 21:04, pages 283-289.
Crossref

Yang Yang, Ruana Cardoso Lima, Sara Gemini-Piperni, Luciana Magalhães Rebelo Alencar & Ralph Santos-Oliveira. (2021) Graphene Quantum Dots for Molecular Radiotherapy: Radiolabeled Graphene Quantum Dots with Radium ( 223 Ra) Showed Potent Effect Against Bone Cancer . Journal of Biomedical Nanotechnology 17:9, pages 1858-1865.
Crossref

Reyhaneh Manafi-Farid, Fardad Masoumi, Ghasemali Divband, Bahare Saidi, Bahar Ataeinia, Fabian Hertel, Gregor Schweighofer-Zwink, Agnieszka Morgenroth & Mohsen Beheshti. (2020) Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain. Journal of Clinical Medicine 9:8, pages 2622.
Crossref

Rosj Gallicchio, Pietro A. Mastrangelo, Anna Nardelli, Pier Paolo Mainenti, Antonio P. Colasurdo, Matteo Landriscina, Giuseppe Guglielmi & Giovanni Storto. (2019) Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why. Tumori Journal 105:5, pages 367-377.
Crossref

I.A. Marques, A.R. Neves, A.M. Abrantes, A.S. Pires, E. Tavares-da-Silva, A. Figueiredo & M.F. Botelho. (2018) Targeted alpha therapy using Radium-223: From physics to biological effects. Cancer Treatment Reviews 68, pages 47-54.
Crossref

Chris Parker, Axel Heidenreich, Sten Nilsson & Neal Shore. (2018) Current approaches to incorporation of radium-223 in clinical practice. Prostate Cancer and Prostatic Diseases 21:1, pages 37-47.
Crossref

Eva Mercier, Daniel Velasco, Marta Cabezas, Cristina Agut & Meritxell Villalon. (2018) Cost-effectiveness Analysis of Radium-223 Dichloride in Metastatic Castration-Resistant Prostate Cancer Patients Without Previous Chemotherapy Treatment in Spain. Journal of Health Economics and Outcomes Research, pages 1-14.
Crossref

Eva Tirado, Daniel Callejo Velasco, Marta Rubio Cabezas, Cristina Moretones Agut & Meritxell Granell Villalón. (2018) Cost-effectiveness Analysis of Radium-223 Dichloride in Metastatic Castration-Resistant Prostate Cancer Patients Without Previous Chemotherapy Treatment in Spain. Journal of Health Economics and Outcomes Research 6:1, pages 1-14.
Crossref

Chethan Ramamurthy, Jamie Doyle, Robert G. Uzzo, Alexander Kutikov, Marc C. Smaldone & Daniel M. Geynisman. (2017) Role of collaboration between urologists and medical oncologists in the advanced prostate cancer space. Urologic Oncology: Seminars and Original Investigations 35:12, pages 665-669.
Crossref

Sergio Baldari, Giuseppe Boni, Roberto Bortolus, Orazio Caffo, Giario Conti, Giuseppe De Vincentis, Fabio Monari, Giuseppe Procopio, Daniele Santini, Ettore Seregni & Riccardo Valdagni. (2017) Management of metastatic castration-resistant prostate cancer: A focus on radium-223. Critical Reviews in Oncology/Hematology 113, pages 43-51.
Crossref

Tiziana Magnani, Lara Bellardita, Augusto Caraceni, Filippo de Braud, Giuseppe Procopio, Roberto Salvioni & Riccardo Valdagni. 2017. Bone Metastases from Prostate Cancer. Bone Metastases from Prostate Cancer 281 293 .

Luigia Florimonte, Luca Dellavedova & Lorenzo Stefano Maffioli. (2016) Radium-223 dichloride in clinical practice: a review. European Journal of Nuclear Medicine and Molecular Imaging 43:10, pages 1896-1909.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Radium-223 dichloride: illustrating the benefits of a multidisciplinary approach for patients with metastatic castration-resistant prostate cancer

Articles from other publishers (12)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Radium-223 dichloride: illustrating the benefits of a multidisciplinary approach for patients with metastatic castration-resistant prostate cancer

Citations (12)

Articles from other publishers (12)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date